Metlife Inc (NYSE:MET) – Analysts at B. Riley issued their Q3 2019 earnings per share (EPS) estimates for Metlife in a research note issued on Monday, October 21st. B. Riley analyst R. Binner forecasts that the financial services provider will post earnings of $1.42 per share for the quarter. B. Riley currently has a “Neutral” rating on the stock.
Several other brokerages also recently weighed in on MET. Zacks Investment Research raised shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 target price for the company in a research note on Friday, August 2nd. ValuEngine downgraded shares of Metlife from a “sell” rating to a “strong sell” rating in a research note on Monday. Wells Fargo & Co boosted their target price on shares of Metlife from $55.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, July 11th. Citigroup cut their target price on shares of Metlife from $42.00 to $41.00 and set a “sell” rating for the company in a research note on Friday, September 13th. Finally, Morgan Stanley cut their target price on shares of Metlife from $54.00 to $53.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 20th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. Metlife has a consensus rating of “Hold” and a consensus target price of $49.51.
Metlife (NYSE:MET) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.07. The business had revenue of $16.45 billion during the quarter, compared to the consensus estimate of $16.43 billion. Metlife had a return on equity of 9.75% and a net margin of 9.28%. The business’s revenue was down 22.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.30 EPS.
The company also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Tuesday, November 5th will be paid a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 3.78%. Metlife’s payout ratio is 32.65%.
A number of hedge funds have recently made changes to their positions in MET. Kavar Capital Partners LLC purchased a new stake in Metlife in the 2nd quarter valued at about $25,000. Motco grew its holdings in Metlife by 160.6% in the 2nd quarter. Motco now owns 516 shares of the financial services provider’s stock valued at $26,000 after buying an additional 318 shares during the period. Coastal Capital Group Inc. purchased a new stake in Metlife in the 2nd quarter valued at about $30,000. Meeder Asset Management Inc. grew its holdings in Metlife by 2,474.2% in the 2nd quarter. Meeder Asset Management Inc. now owns 798 shares of the financial services provider’s stock valued at $40,000 after buying an additional 767 shares during the period. Finally, Clean Yield Group grew its holdings in Metlife by 3,681.8% in the 2nd quarter. Clean Yield Group now owns 832 shares of the financial services provider’s stock valued at $41,000 after buying an additional 810 shares during the period. 75.60% of the stock is owned by hedge funds and other institutional investors.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
See Also: What is a growth and income fund?
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.